whom-to-test

NEW! Patient Profile Navigator

Canada - English

Brazil

Canada - Français

Deutschland

France

Ελλάδα

Ireland

Latin America

Netherlands

Spain

Switzerland

United Kingdom

United States

日本

International

Physician Login

Healthcare Professionals

ASCO Guidelines
Updated ASCO Guidelines strongly recommend use of the Oncotype DX Breast Recurrence Score^® Test in node-negative and the majority of node-positive early-stage breast cancer patients

READ PUBLICATION
- Oncotype DX Breast Recurrence Score
- About the test
- Value in clinical practice
  - Node-Negative
  - Node-Positive NEW DATA
- Clinical evidence
  - Node-Negative
  - Node-Positive NEW DATA
- Inclusion in guidelines
- Prognostic vs predictive
- Interpreting the results
- How to order a test
- Patient Profile Navigator NEW
- Videos and webcasts
Patients and Caregivers

Do You Have a Question?

Contact Us
- Breast cancer
- About the test
- Eligibility and testing
- Oncotype DX Results: What to expect
- Hear from our patients NEW
- FAQs and patient resources
Press Room
Contact Us

×

You are now entering a page intended for healthcare professionals only and not by members of the public.

Continue

Go Back

Oncotype DX Breast Recurrence Score

Topics

Share

About the test
Value in clinical practice
- Node-Negative
- Node-Positive NEW DATA
Clinical evidence
- Node-Negative
- Node-Positive NEW DATA
Inclusion in guidelines
Prognostic vs predictive
Interpreting the results
How to order a test
Patient Profile Navigator NEW
Videos and webcasts

Contact Us

GET IN TOUCH

×

You are now leaving this site. Any third party link you select from this site may take you to an Exact Sciences website intended for US audiences or a website that is not affiliated with Exact Sciences.

I Agree

Oncotype DX Breast Recurrence Score
- About the test
- Value in clinical practice
  - Node-Negative
  - Node-Positive
- Clinical Evidence
  - Node-Negative
  - Node-Positive
- Inclusion in guidelines
- Prognostic vs. Predictive
- Interpreting the results
- How to order a test
Patients And Caregivers

Home
Privacy Policy
HIPAA Notice
Do Not Sell My Information
Terms & Conditions
Worldwide Websites

In the US and certain other jurisdictions, Genomic Health, Oncotype DX, Oncotype IQ, Recurrence Score, Oncotype DX Breast Recurrence Score, and Oncotype DX Colon Recurrence Score are registered trademarks, and "Making cancer care smarter" is a pending registered trademark of Genomic Health, Inc. Exact Sciences is a registered trademark of Exact Sciences Corporation.

×

ASCO Guidelines

Do You Have a Question?

Share

Contact Us